BS
AMPE

Boenning & Scattergood’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Boenning & Scattergood’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-33
Closed -$5K – 286
2018
Q3 		$5K Hold
33
– – ﹤0.01% 271
2018
Q2 		$22K Buy
+33
New +$24.7K 0.01% 272

Other funds holding AMPE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
MA
Montag & Associates Atlanta, Georgia $2.15B AUM 20.86% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return

Boenning & Scattergood's AMPE Position: Q4 2018 in Review

Boenning & Scattergood sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2018, closing a stake of 33 shares — an estimated $5K sold.

Boenning & Scattergood first reported a position in AMPE in Q2 2018 and held it in 2 quarters. The position peaked at $22K in Q2 2018. 89 funds tracked by Wall St. Rank hold AMPE as of Q4 2018.

  • Boenning & Scattergood reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2018 after selling out during the quarter.
  • Boenning & Scattergood sold 33 Ampio Pharmaceuticals Inc. shares in Q4 2018, an estimated $5K.
  • Boenning & Scattergood first reported a position in Ampio Pharmaceuticals Inc. in Q2 2018 and held it in 2 quarters.
  • Boenning & Scattergood's Ampio Pharmaceuticals Inc. position peaked at $22K in Q2 2018.
  • 89 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2018.

Based on Boenning & Scattergood's 13F filing for Q4 2018, filed 22 Jan 2019.